Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes
Stem cell derived insulin producing cells or islets have shown promise in reversing Type 1 Diabetes (T1D), yet successful transplantation currently necessitates long-term modulation with immunosuppressant drugs. An alternative approach to avoiding this immune response is to utilize an islet macroenc...
Main Authors: | , , , , , , |
---|---|
Other Authors: | , |
Format: | Article |
Language: | English |
Published: |
Wiley,
2022-01-13T15:37:15Z.
|
Subjects: | |
Online Access: | Get fulltext |